RNAi is a powerful tool to achieve suppression of a specific gene expression and therefore it has tremendous potential for gene therapy applications. A number of vector systems have been developed to express short-hairpin RNAs (shRNAs) to produce siRNAs within mammalian T-cells, primary hematopoietic stem/progenitor cells (HSPC), human peripheral blood mononuclear cells, and in animal model systems. Among these, vectors based on lentivirus backbones have significantly transformed our ability to transfer shRNAs into nondividing cells, such as HSPC, resulting in high transduction efficiencies. However, delivery and long-term expression of shRNAs should be carefully optimized for efficient knock down of target gene without causing cytotoxicity in mammalian cells. Here, we describe our protocols for the development of shRNA against a major HIV co-receptor/chemokine receptor CCR5 and the use of lentiviral vectors for stable shRNA delivery and expression in primary human PBMC and HSPC.
Introduction
Lentivirus vectors are powerful tool to efficiently transduce and express shRNAs in mammalian cells and to knock down specific target gene expression through RNA interference. Initially, shRNA was expressed from a transcriptionally strong U6 pol III promoter as an internal RNA polymerase promoter from a lentiviral vector. The U6 promoter was frequently used in order to effectively knock down a target mRNA. However, we and others recognized that continuous high level of shRNA over expression from the U6 promoter could cause cytotoxicity in vector transduced cells [1] . High level of shRNA expression might interfere the function of endogenous microRNA since maturation of shRNA to siRNA utilizes the endogenous microRNA processing pathway and miRNAs plays a vital role in normal cellular functions. We learned from our experience of knocking down CCR5 expression in human peripheral blood mononuclear cells that a potent shRNA must be identified and expressed at lower level using transcriptionally weaker H1 RNA polymerase III promoter to stably knockdown CCR5 gene expression and to avoid cytotoxic
4.
1 mg/ml Recombinant Fibronectin (RetroNectin) stock solution.
5.
FACS Buffer: 2 % FCS in 1× PBS.
6.
10F RPMI: RPMI-1640 supplemented with 10 % FCS and 1 % glutamine/ penicillin/streptomycin (GPS).
7.
20F RPMI: RPMI-1640 supplemented with 20 % FCS and 1 % glutamine/ penicillin/streptomycin (GPS).
8.
Infection medium: Yssel's Serum-Free T-cell Medium supplemented with 2 % bovine serum albumin (BSA), 2.5 μg/ml Fungizone and 0.45 mg/ml Piperacillin and Tazobactram (PT, also known as Zocyn).
9.
Cytokine medium: 20F RPMI supplemented with 50 ng/ml IL-6, 50 ng/ml IL-3, 50 ng/ml SCF.
10.
Titrated VSV-G pseudotyped lentiviral vector stocks.
11.
Fix buffer: 1 % Formaldehyde in 1× PBS.
CCR5 Detection in Humanized Mouse Blood

1.
10× Red blood cell lysis buffer: 82.9 g of Ammonium Chloride, 10.0 g of potassium bicarbonate, 0.37 g of ethylenediamine tetraacetic acid (EDTA) disodium salt in 1L water (see Note 4 ).
2.
1× Red blood cell lysis buffer (see Note 5 ).
3.
FACS buffer: 2 % FCS in 1× PBS.
4.
Fix buffer: 1 % formaldehyde in 1× PBS.
5.
Master Mix1: 0.5 μl of CD45-eFluore 450, 0.5 μl of CD3-APCH7, 0.5 μl of CD4-APC, 0.5 μl of CD8-PerCPCy5.5, 0.5 μl of CD19-V500, 0.5 μl of CCR5 -PC7 in 100 μl of FACS buffer (see Note 6 ).
Methods
Construction of shRNA Expressing Lentivirus Vector
1.
Synthesize a forward and a reverse oligonucleotide DNAs for a shRNA based on the design described in Fig. 1b. 
2.
Dilute the forward and reverse oligonucleotides in TE at a concentration of 10 pmol/μl each. Mix each 10 μl of forward and reverse oligo DNA into 0.5 mL tube and incubate at 95 °C for 10 min and slowly cool down to room temperature.
4 10× Red lysis buffer is filtered with 45 μm filter and stored at 4 °C. 5 1× red blood cell lysis buffer should be used at room temperature. Dilute 10× RBC buffer with ddH 2 O and filter. Store at 4 °C. 6 We use clone 2D7 for anti-human CCR5 antibody for CCR5 cell surface detection by flow cytometry.
3.
Digest 1 μg of pBS-hH1.3 with 1 U of BamH I and Xho I at 37 °C for 1 h in NEBuffer4. Run the product on 1 % agarose gel, cut the 3130 bp DNA fragment and purify using the gel extraction kit.
4.
Incubate purified vector and 7 μl annealed oligos with T4 DNA ligase at 16 °C for 1 h in 10 μl of 1× T4 DNA polymerase buffer (see Note 7 ).
5.
Transform competent cells with the product by electroporation. Thaw competent cells on ice. Chill an electroporation cuvette and ligation sample on ice. Add 1 μl of ligation sample into 55 μl of competent cells and transfer into electroporation cuvette gently, and apply one pulse.
6.
Immediately add 250 μl of 2× YT medium (see Note 8 ).
7.
Plate all of them into LB agar plate containing 50 μg/mL ampicillin using a spreader.
8.
Incubate the plate at 37 °C overnight.
9.
Pick 5-10 single colonies with toothpick and culture in 2 mL of 2× YT containing 50 μg/mL ampicillin medium overnight with constant shaking at 200 rpm (see Note 9 ).
10.
Carry out Mini prep following the manufacturer's instructions.
11.
Confirm sequence using M13 fwd/M13 rev primers.
12.
Insert: Digest 1 μg of pBS-hH1-3 plasmid DNA with 1 U of Xho I and Xba I at 37 °C for 1 h in NEBuffer4 then, run the product on 1 % agarose gel, cut the 294 bp band and purify using gel extraction kit.
13.
Vector: Digest 1 μg of FG12 vector with 1 U of Xho I and Xba I at 37 °C for 1 h in NEBuffer4. Run the product on 1 % agarose gel, isolate the 9865 bp band and purify using gel extraction kit.
14.
Incubate purified vector (at least 50 ng) and insert with 1 μl of T4 DNA Ligase at 16 °C for 1 h in 10 μl of 1× T4 DNA polymerase buffer.
15.
16.
Immediately add 250 μl of 2× YT medium into the cells.
17.
18.
19.
Pick 5-10 single colonies with toothpick and culture in 2 mL of 2× YT medium containing 50 μg/mL ampicillin overnight with constant shaking at 200 rpm.
20.
21.
Digest 5 μl of miniprep sample with 1 U of Afe I and Xba I enzyme in NEBuffer4 and confirm ~380 bp insert (see Note 10 ).
Transfection of 293-T Cells for Production of VSV-G Pseudotyped Lentiviral Vectors
1.
Culture 15 × 10 6 293-T cells into T-175 flasks in 25 ml culture medium 1 day before.
2.
On the day of transfection, change the medium into chloroquine medium (40 μl of 10 mM chloroquine + 10 ml culture medium).
3.
Make a master mix of the viral DNA in a screw cap tube (viral DNA + 2 M calcium chloride + ddH 2 O such that the total volume is 1100 μl.
4.
Add 10 μg of vector DNA to the master mix. This is solution A.
5.
Incubate solution A on ice for 5 min.
6.
For solution B, add 1110 μl 2× HBS into a 50 ml conical tube.
7.
Adding solution A to solution B: Using a p200 micropipette, Add solution A dropwise by the sides of the tube containing solution B. Shake tube to mix drops. The mixture will collect on the bottom of the tube. This is solution C.
8.
Incubate solution C on ice for 20 min.
9.
After 20 min, add solution C dropwise to the T-175 flask containing cells. Solution C should be added to the culture media in the flask and should not touch the cells.
10.
Slowly swirl the media in the flask to mix the solution C.
11.
Slowly lay the flask flat so that the media touched the cells.
12.
Incubate for 8 h at 37 °C, 5 % CO 2 .
13.
After 8 h, slowly remove all the media in the flask and add 35 ml of culture media.
14.
Incubate at 37 °C, 5 % CO 2 .
Concentration of Vector, Resuspension, and Storage
1.
Observe infected 293-T cells under the microscope for infection by checking for GFP expression.
2.
Harvest supernatant in a 50 ml tube and filter the supernatant using the Steriflip filter unit.
3.
Concentrate VSV-G-psuedotyped virions from the supernatant by ultracentrifugation. Transfer the filtrate (containing the vector) into an ultracentrifuge tube (Ultraclear 38.5 ml Beckman Coulter).
4.
Slowly add 5 ml of 10 % sucrose buffer to the tubes by touching the pipette all the way to the bottom of the ultracentrifuge tube and releasing the sucrose buffer slowly. This will create a sucrose cushion and will help avoid the coprecipitation of unwanted particles, resulting in vector of significantly higher purity.
5.
Use serum-free medium to balance the tubes to within 30 mg, and then load in an SW32 rotor.
6.
Centrifuge at 67214 × g at 4 °C for 90 min. The brake must be inactivated to prevent disturbing the viral pellet during deceleration.
7.
Discard the supernatant by inversion and leave the ultracentrifuge tube inverted for 90 s on absorbent paper towel.
8.
Resuspend the viral pellet in 100 μl of HBSS and seal the ultracentrifuge tubes with parafilm. Store the tubes overnight at 4 °C.
9.
Following overnight storage at 4 °C, carefully mix the vector by vigorous pipetting, and then store at −80 °C in small aliquots.
Titration of Lentivirus Vector Stocks
1.
Plate 293-T cells at 0.5 × 10 5 cells/500 μl in 24-well plate 1 day before the infection.
2.
Prepare titration medium containing 2/8 IMDM + 8 μl/ml polybrene.
3.
Thaw an aliquot of the vector on ice, and prepare a serial dilution of vector with the titration media (see Note 11 ).
4.
Dilution 1:1/300 diluted vector:1 μl of concentrated vector + 300 μl of titration media.
5.
Dilution 2:1/3000 diluted vector:30 μl of 1/300 diluted vector + 270 μl of titration media.
6.
Dilution 3:1/30,000 diluted vector:30 μl of 1/3000 diluted vector + 270 μl of titration media.
7.
Remove media from plated 293-T cells and add 250 μl of the serially diluted vector to corresponding wells (see Note 12 ).
8.
Incubate the infected cells for 2 h at 37 °C, 5 % CO 2 , incubator.
9.
After 2 h, remove the supernatant and add 1 ml of 2/8 IMDM to each well.
10.
Three days post-infection, remove all the supernatant from infected 293-T cells and wash cells with 1× PBS.
11.
Add 100 μl of trypsin-EDTA solution to each well and incubate for 2 min at 37 °C, 5 % CO 2 incubator.
12.
Observe under the microscope to see if all the cells have detached from the well surface. If not then keep for an additional 2 min in the incubator.
13.
Add 1 ml of 2/8 IMDM to wells to block trypsin-EDTA action and flush cells with the help of micropipette.
14.
Count the cells and take 0.1 × 10 6 cells in 1.5 ml screw-cap tubes.
15.
Centrifuge at 3500 × g for 1 min and aspirate supernatant.
16.
Add 500 μl of fix buffer to each tube and transfer to FACS tubes.
17.
Acquire samples by fluorescence-activated cell sorting (FACS) in order to measure % EGFP-positive cells.
18.
Based on % EGFP-positive cells, calculate the titer of the vector according to the formula indicated below.
a.
Select the dilution which shows closest to tenfold increase in % EGFP-positive cells as compared to previous dilution. 
7.
Incubate on ice for a total of 30 min, mixing every 10 min.
8.
Add 7 ml of cold FACS buffer.
9.
Place the 15 ml tube containing the cells and the beads in the magnet box and wait for 3 min until the red magnet beads attach to the side of the tube.
10.
Decant supernatant (containing the cells of interest) into a fresh 15 ml conical tube.
11.
Check percentage and purity of CD8+ depleted cells by staining 0.1 × 10 6 cells with antibodies against CD4, CD8, CD27, and CD45RA.
12.
Spin down the CD8+ depleted cells and resuspend the cells in 20F RPMI. Count the cells.
13.
Seed 2 × 10 6 CD8+ depleted cells per ml and activate the cells with PHA (Final concentration should be 2.5 μg/ml) in 20F RPMI for 3 days.
14.
Post-activation, wash the CD8+ depleted cells with warm 10F RPMI and resuspend the cells in growth medium in a 96-well plate at 0.4 × 10 6 cells/100 μl/well.
15.
Incubate cells for 4 h at 37 °C, 5 % CO 2 .
16.
Prepare 50 μl of polybrene/vector solution (48.8 μl of 10F RPMI + 1.2 μl of polybrene + calculated amount of vector). The final concentration of polybrene should be 8 μg/ml.
17.
After 4 h, add the polybrene/vector solution to the cells and mix well by pipetting.
18.
Incubate cells for 2 h at 37 °C, 5 % CO 2 incubator.
19.
After 2 h, remove 140 μl of the culture medium carefully. Try not to disturb the cells.
20.
Add 250 μl of growth medium and Incubate cells overnight at 37 °C, 5 % CO 2 .
21.
Incubate cells overnight at 37 °C, 5 % CO 2 .
22.
Collect all cells per well. Make sure that there are no cells left in the well by observing the wells under the microscope.
23.
Wash the cells with 1 ml of pre-warmed 10F RPMI (optional).
24.
Transfer cells to a 24-well plate and add 1 ml of growth medium into each well.
25.
Incubate at 37 °C, 5 % CO 2 . Transgene expression can be assessed within 48-72 h.
26.
After 72 h, collect and count the cells. Centrifuge the cells at 3,500 × g for 1 min at room temperature.
27.
Resuspend cells in growth media at 1 × 10 6 cells/ml.
28.
Stain remaining cell from each sample with 50 μl of FACS buffer + 1 ml of antibody against CD4, CD8, CD27 and CD45RA for 20 min at room temperature in the dark.
29.
Add 1 ml 1× PBS and centrifuge at 3,500 × g for 1 min.
30.
Add 300 μl fix buffer and acquire cell events by flow cytometer and assess EGFP expression.
Transduction of CD34+ Cells with Lentiviral Vector Carrying shRNA
1.
Prepare 20 μg/ml RetroNectin-PBS solution (working solution) for coating the 24-well plate.
2.
Dispense 500 μl of RetroNectin-PBS solution into each well. Incubate for 2 h at room temperature in the dark.
3.
Remove the RetroNectin-PBS solution. This can be reused if stored at 4 °C.
4.
Dispense 500 μl of FACS buffer into each well for blocking. Incubate for 30 min at room temperature in the dark.
5.
Aspirate FACS buffer and wash wells once with 500 μl 1× PBS. Do not remove PBS from wells.
6.
Quick thaw frozen CD34+ cells into 5 ml pre-warmed infection medium.
7.
Centrifuge the CD34+ cells at 314 × g for 5 min.
8.
Resuspend cell pellet in 1 ml infection medium.
9.
Count the cells. Bring concentration of cells to 1 × 10 6 cells/ml.
10.
Remove PBS from the wells. CD34+ cells should be cultured at 0.25 × 10 6 cells per well; therefore add 250 μl of cells to each well.
11.
Incubate cells for 1 h at 37 °C, 5 % CO 2 , incubator.
12.
Add 250 μl infection medium to each well such that there is 500 μl medium in each well.
13.
A MOI of 0.3 is generally used to obtain transduction efficiencies of >50 %. CD34+ cells does not require the addition of polybrene and is not augmented by the presence of RetroNectin. Add calculated amount of vector to the designated well.
14.
15.
The next day, add 800-1000 μl of 10F RPMI to each well.
16.
Collect all cells per well. Make sure that there are no cells left in the well by observing the well under the microscope.
17.
Centrifuge tubes at 453 × g for 5 min at room temperature.
18.
Resuspend cell pellet again in 800-1000 μL OF 10F RPMI. Repeat step 17. 
